Marketing-authorisation holder · Sweden
Hansa Biopharma Ab
4 medicines in 4 countries, as authorisation holder and marketer.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| IDEFIRIXPolvere per concentrato per soluzione per infusione | Imlifidase | Italy | Authorised | |
| Idefirix | Imlifidase | EU (EMA) | Authorised | 2020 |
| IDEFIRIX 11 MG DE POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION11 mg · Polvo para concentrado para solución para perfusión | Imlifidase | Spain | Marketed | 2021 |
| Idefirix 11 mg, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Imlifidase | Netherlands | Authorised | 2020 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 1 | 1 | 0 | Companies |



